Sinopharm
1099.HK
A$3.80
Share price
-1.32%
Change (1 day)
5.69%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Sinopharm (1099.HK) - Cash on Hand
Cash on Hand as of December 2024 : A$11.42 Billion
According to Sinopharm's latest financial reports the company has A$11.42 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sinopharm - Cash on Hand chart (from 2008 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | A$13.24 B | 12.61% |
| 2022-12-31 | A$11.76 B | 24.84% |
| 2021-12-31 | A$9.42 B | -5.87% |
| 2020-12-31 | A$10.01 B | 24.96% |
| 2019-12-31 | A$8.01 B | -3.76% |
| 2018-12-31 | A$8.32 B | 30.46% |
| 2017-12-31 | A$6.38 B | 24.89% |
| 2016-12-31 | A$5.11 B | 20.83% |
| 2015-12-31 | A$4.22 B | 40.69% |
| 2014-12-31 | A$3.00 B | 15.88% |
| 2013-12-31 | A$2.59 B | 71.45% |
| 2012-12-31 | A$1.51 B | -25.53% |
| 2011-12-31 | A$2.03 B | 82.53% |
| 2010-12-31 | A$1.11 B | -9.77% |
| 2009-12-31 | A$1.23 B | 196.76% |
| 2008-12-31 | A$0.41 B | 35.54% |
| 2007-12-31 | A$0.30 B | 2.62% |
| 2006-12-31 | A$0.29 B |